Villarosa, Henry .

HRN: 23-23-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/25/2023
07/02/2023
IV
1.5g
Q8
Cellulitis
Waiting Final Action 
06/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/25/2023
07/02/2023
IV
600mg
Q6
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: